These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28562527)

  • 1. Successful treatment of infliximab in a patient with scleroderma: a case report.
    Li T; Liu Y; Xu H
    Medicine (Baltimore); 2017 Jun; 96(22):e6737. PubMed ID: 28562527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of TNF-α inhibitors in systemic sclerosis.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Puppo F
    Immunotherapy; 2014; 6(3):283-9. PubMed ID: 24762073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.
    Distler JH; Jordan S; Airo P; Alegre-Sancho JJ; Allanore Y; Balbir Gurman A; Caporali R; Caramaschi P; Carreira PE; Chizzolini C; Cutolo M; Tuncay Duruöz M; Farge-Bancel D; Hesselstrand R; Iannone F; De Keyser F; Kucharz EJ; Launay D; García de la Peña Lefebvre P; Lukacova O; Marasini B; Martinovic D; Marques Neto JF; Radic M; Rednic S; Riemekasten G; Rovensky J; Seidel MF; Senel S; Smith V; Sunderkötter C; Ton E; van Laar JM; Matucci-Cerinic M; Müller Ladner U; Distler O
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S40-5. PubMed ID: 21586217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
    Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
    JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab reduces activated myeloid dendritic cells, different macrophage subsets and CXCR3-positive cells in granuloma annulare.
    Bürgler C; Vinay K; Häfliger S; Klötgen HW; Yawalkar N
    J Dermatol; 2019 Sep; 46(9):808-811. PubMed ID: 31290564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
    PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNFα treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature.
    Basoulis D; Fragiadaki K; Tentolouris N; Sfikakis PP; Kokkinos A
    Metabolism; 2016 Apr; 65(4):569-73. PubMed ID: 26975548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
    Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
    Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension.
    Bargagli E; Galeazzi M; Bellisai F; Volterrani L; Rottoli P
    Respiration; 2008; 75(3):346-9. PubMed ID: 16369127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
    Denton CP; Engelhart M; Tvede N; Wilson H; Khan K; Shiwen X; Carreira PE; Diaz Gonzalez F; Black CM; van den Hoogen FH
    Ann Rheum Dis; 2009 Sep; 68(9):1433-9. PubMed ID: 18782794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment.
    Koga A; Kajihara I; Yamada S; Makino K; Ichihara A; Aoi J; Makino T; Fukushima S; Jinnin M; Ihn H
    J Dermatol; 2016 May; 43(5):522-5. PubMed ID: 26507968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granuloma annulare: a case treated with infliximab successfully.
    Giunta A; Chiricozzi A; Cannizzaro MV; Dattola A; Ruzzetti M; Nisticò SP; Chimenti S
    G Ital Dermatol Venereol; 2017 Apr; 152(2):193-195. PubMed ID: 28166622
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic Scleroderma: Are There Any Clues?
    Jedlickova H; Durčanská V; Vašků V
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):78-80. PubMed ID: 27149136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyarteritis Nodosa with a Systemic Inflammatory Response Pattern: Effectiveness of anti-TNF.
    Tous-Romero F; Rodríguez-Almaraz E; Rodríguez-Peralto JL; Postigo-Llorente C
    Actas Dermosifiliogr; 2017 Oct; 108(8):787-790. PubMed ID: 28372782
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo.
    Clements P; Lachenbruch P; Furst D; Paulus H
    Arthritis Rheum; 1993 Nov; 36(11):1575-9. PubMed ID: 8240434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn's disease during infliximab therapy.
    Numakura T; Tamada T; Nara M; Muramatsu S; Murakami K; Kikuchi T; Kobayashi M; Muroi M; Okazaki T; Takagi S; Eishi Y; Ichinose M
    BMC Pulm Med; 2016 Feb; 16():30. PubMed ID: 26864464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review.
    Do N; Ringold S; Brandling-Bennett H
    Pediatr Dermatol; 2019 Nov; 36(6):932-935. PubMed ID: 31576593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.